Skip to main content
Top
Published in: Intensive Care Medicine 7/2014

01-07-2014 | Editorial

Treatment thresholds for hyperglycemia in critically ill patients with and without diabetes

Authors: Paul E. Marik, Moritoki Egi

Published in: Intensive Care Medicine | Issue 7/2014

Login to get access

Excerpt

Hyperglycemia is exceedingly common in critically ill patients. Although there is no accepted definition of acute hyperglycemia in the critical care setting, it is generally considered to be above 180–220 mg/dl (10.0–12.2 mmol/l). In the study by Plummer and colleagues reported in this issue of Intensive Care Medicine only 22.7 % of ICU patients were normoglycemic [1]. Glycemic control and the optimal blood glucose target are a subject of enormous controversy in critically ill patients. Retrospective and cohort studies in both ICU and hospitalized non-ICU patients have demonstrated a strong association between hyperglycemia and poor clinical outcomes [2]. It had therefore been assumed that “strict” glycemic control would improve patient outcomes. In 2001 van den Berghe et al. [3] reported that tight glycemic control (80–110 mg/dl, 4.4–6.1 mmol/l) improved the outcome of critically ill patients in a surgical intensive care unit. Subsequent studies, the most important being the NICE-SUGAR study, demonstrated that intensive glucose control (81–108 mg/dl, 4.5–6.0 mol/l) increased mortality when compared to conventional glucose control (144–180 mg/dl, 8.0–10.0 mmol/l) [4]. We have previously argued that hyperglycemia is a marker of illness severity rather than a cause of poor outcome [5]. Indeed, the degree of hyperglycemia is related to the degree of activation of the stress response. Stress hyperglycemia is regarded as an evolutionary adaptive response which allows the host to survive during periods of severe stress [5]. The neuroendocrine response to stress is characterized by excessive gluconeogenesis, glycogenolysis, and insulin resistance, with increased hepatic output of glucose (gluconeogenesis) being the major cause of stress hyperglycemia. Insects, worms, and all verterbrates including fish develop stress hyperglycemia when exposed to stress [5]. Stress hyperglycemia provides a source of fuel for the immune system and brain at a time of stress. While mild to moderate stress hyperglycemia is protective it is likely that severe stress hyperglycemia may be deleterious. However, the blood glucose threshold above which stress hyperglycemia becomes harmful is unknown. Furthermore, we suggest that both the duration and the degree of hyperglycemia are important in determining whether hyperglycemia is protective or harmful [5]. It seems most unlikely that a few days of hyperglycemia would be harmful; indeed attempts at rapid correction of blood glucose in these patients may be harmful. …
Literature
1.
go back to reference Plummer MP, Bellomo R, Cousins CE, Annink CE, Sundararajan K, Reddi BA, Raj JP, Chapman MJ, Horowitz M, Deane AM (2014) Dysglycaemia in the critically ill and the interaction of chronic and acute glycaemia with mortality. Intensive Care Med. doi:10.1007/s00134-014-3287-7 PubMed Plummer MP, Bellomo R, Cousins CE, Annink CE, Sundararajan K, Reddi BA, Raj JP, Chapman MJ, Horowitz M, Deane AM (2014) Dysglycaemia in the critically ill and the interaction of chronic and acute glycaemia with mortality. Intensive Care Med. doi:10.​1007/​s00134-014-3287-7 PubMed
2.
go back to reference Badawi O, Waite MD, Fuhrman SA, Zuckerman IH (2012) Association between intensive care unit-acquired dysglycemia and in-hospital mortality. Crit Care Med 40:3180–3188PubMedCrossRef Badawi O, Waite MD, Fuhrman SA, Zuckerman IH (2012) Association between intensive care unit-acquired dysglycemia and in-hospital mortality. Crit Care Med 40:3180–3188PubMedCrossRef
3.
go back to reference van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345:1359–1367PubMedCrossRef van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345:1359–1367PubMedCrossRef
4.
go back to reference The NICE-Sugar Study Investigators (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:1283–1297 The NICE-Sugar Study Investigators (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:1283–1297
6.
go back to reference Qaseem A, Humphrey LL, Chou R, Snow V, Shekelle P (2011) Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med 154:260–267PubMedCrossRef Qaseem A, Humphrey LL, Chou R, Snow V, Shekelle P (2011) Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med 154:260–267PubMedCrossRef
7.
go back to reference Agus MS, Steil GM, Wypij D, Costello JM, Laussen PC, Langer M, Alexander JL (2012) Tight glycemic control versus standard care after pediatric cardiac surgery. N Engl J Med 367:1208–1219PubMedCentralPubMedCrossRef Agus MS, Steil GM, Wypij D, Costello JM, Laussen PC, Langer M, Alexander JL (2012) Tight glycemic control versus standard care after pediatric cardiac surgery. N Engl J Med 367:1208–1219PubMedCentralPubMedCrossRef
8.
go back to reference Minakata K, Sakata R (2013) Perioperative control of blood glucose level in cardiac surgery. General Thorac Cardiovasc Surg 61:61–66CrossRef Minakata K, Sakata R (2013) Perioperative control of blood glucose level in cardiac surgery. General Thorac Cardiovasc Surg 61:61–66CrossRef
9.
go back to reference (2014) Executive summary: standards of medical care in diabetes—2014. Diabetes Care 37(Suppl 1):S5–13 (2014) Executive summary: standards of medical care in diabetes—2014. Diabetes Care 37(Suppl 1):S5–13
10.
go back to reference Olson DE, Rhee MK, Herrick K, Ziemer DC, Twombly JG, Phillips LS (2010) Screening for diabetes and pre-diabetes with proposed A1C-based diagnostic criteria. Diabetes Care 33:2184–2189PubMedCentralPubMedCrossRef Olson DE, Rhee MK, Herrick K, Ziemer DC, Twombly JG, Phillips LS (2010) Screening for diabetes and pre-diabetes with proposed A1C-based diagnostic criteria. Diabetes Care 33:2184–2189PubMedCentralPubMedCrossRef
11.
go back to reference Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Hegarty C, Bailey M (2008) Blood glucose concentration and outcome of critical illness: the impact of diabetes. Crit Care Med 36:2249–2255PubMedCrossRef Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Hegarty C, Bailey M (2008) Blood glucose concentration and outcome of critical illness: the impact of diabetes. Crit Care Med 36:2249–2255PubMedCrossRef
12.
go back to reference Krinsley JS, Egi M, KIss A, Devendra AM, Schuetz P, Maurer P, Schultz MJ, van Hooijdonk RT, Kiyoshi M, Mackenzie IM, Annane D, Stow P, Nasraway SA, Holewinski S, Holzinger U, Preiser JC, Vincent JL, Bellomo R (2013) Diabetes status and the relation of the three domains of glycemic contril to mortality in critically ill patients: an international multicenter cohort study. Crit Care 17:R37PubMedCentralPubMedCrossRef Krinsley JS, Egi M, KIss A, Devendra AM, Schuetz P, Maurer P, Schultz MJ, van Hooijdonk RT, Kiyoshi M, Mackenzie IM, Annane D, Stow P, Nasraway SA, Holewinski S, Holzinger U, Preiser JC, Vincent JL, Bellomo R (2013) Diabetes status and the relation of the three domains of glycemic contril to mortality in critically ill patients: an international multicenter cohort study. Crit Care 17:R37PubMedCentralPubMedCrossRef
13.
go back to reference Egi M, Bellomo R, Stachowski E, French CJ, Hart G (2006) Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiol 105:244–252CrossRef Egi M, Bellomo R, Stachowski E, French CJ, Hart G (2006) Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiol 105:244–252CrossRef
14.
go back to reference Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C (2006) Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295:1681–1687PubMedCrossRef Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C (2006) Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295:1681–1687PubMedCrossRef
15.
go back to reference Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Taori G, Hegarty C, Bailey M (2011) The interaction of chronic and acute glycemia with mortality in critically ill patients with diabetes. Crit Care Med 39:105–111PubMedCrossRef Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Taori G, Hegarty C, Bailey M (2011) The interaction of chronic and acute glycemia with mortality in critically ill patients with diabetes. Crit Care Med 39:105–111PubMedCrossRef
Metadata
Title
Treatment thresholds for hyperglycemia in critically ill patients with and without diabetes
Authors
Paul E. Marik
Moritoki Egi
Publication date
01-07-2014
Publisher
Springer Berlin Heidelberg
Published in
Intensive Care Medicine / Issue 7/2014
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-014-3344-2

Other articles of this Issue 7/2014

Intensive Care Medicine 7/2014 Go to the issue